Accessibility Menu
 

Cannabis Bioscience International

(OTC) CBIH

Current Price$0.00
Market Cap$3.49M
Since IPO (2018)-98%
5 Year-90%
1 Year-58%
1 Month-50%

Cannabis Bioscience International Financials at a Glance

Market Cap

$3.49M

Revenue (TTM)

$123.63K

Net Income (TTM)

$515.29K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.61 (Low)

Price

$0.00

Volume

769,230

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

CBIH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cannabis Bioscience International

Industry

Life Sciences Tools and Services

Employees

2

CEO

Dante Picazo

Headquarters

Houston, TX 91789, US

CBIH Financials

Key Financial Metrics (TTM)

Gross Margin

-0%

Operating Margin

-3%

Net Income Margin

-4%

Return on Equity

0%

Return on Capital

32%

Return on Assets

-334%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.49M

Shares Outstanding

11.63B

Volume

769.23K

Avg. Volume

8.53M

Financials (TTM)

Gross Profit

$262.92K

Operating Income

$421.37K

EBITDA

$335.53K

Operating Cash Flow

$329.63K

Capital Expenditure

$4.00

Free Cash Flow

$329.63K

Cash & ST Invst.

$12.95K

Total Debt

$420.23K

Cannabis Bioscience International Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$11.21K

-25.0%

Gross Profit

$40.79K

-813.6%

Gross Margin

-3.64%

N/A

Market Cap

$3.49M

N/A

Market Cap/Employee

$1.74M

N/A

Employees

2

N/A

Net Income

$103.93K

+42.7%

EBITDA

$93.26K

+37.8%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$406.05K

+5.0%

Accounts Receivable

$1.27K

-52.0%

Inventory

$0.00

N/A

Long Term Debt

$249.50K

-9.5%

Short Term Debt

$156.64K

-5.2%

Return on Assets

-333.74%

N/A

Return on Invested Capital

31.76%

N/A

Free Cash Flow

$14.60K

+93.5%

Operating Cash Flow

$14.60K

+93.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DHBUFDelivra Health Brands Inc.
$0.11-0.37%
HYEXHealthy Extracts Inc.
$1.27+1.60%
BUDZWEED, Inc.
$0.04-2.17%
AYRWFAyr Wellness Inc.
$0.01+2.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
DGXXDigi Power X
$5.11+0.29%
NOKNokia
$13.42+0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.96-0.02%
CCLCarnival Corp.
$25.77+0.00%

Questions About CBIH

What is the current price of Cannabis Bioscience International?

Cannabis Bioscience International is trading at $0.00 per share.

What is the 52-week range for Cannabis Bioscience International?

Over the past 52 weeks, Cannabis Bioscience International has traded between $0.00 and $0.00.

How much debt does Cannabis Bioscience International have?

As of the most recent reporting period, Cannabis Bioscience International reported total debt of $406,140.

How much cash does Cannabis Bioscience International have on hand?

Cannabis Bioscience International reported $90 in cash and cash equivalents in its most recent financial results.

What is Cannabis Bioscience International’s dividend yield?

Cannabis Bioscience International does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.